Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.40 |
| ▸ | BRD2 | P25440 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 4/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | APEX1 | P27695 | 2/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11031774 | 0.78 | CHRM2 (0.33) | BRD4BRD2CHRM2CHRM5CHRM1 | |
| SCHEMBL27443050 | 0.77 | — | — | |
| SCHEMBL649628 | 0.76 | — | — | |
| SCHEMBL14692624 | 0.75 | — | — | |
| SCHEMBL11825737 | 0.74 | BRD4 (0.31) | BRD4BRD2CHRM2CHRM5CHRM1 | |
| SCHEMBL195054 | 0.72 | — | — | |
| SCHEMBL19448367 | 0.72 | — | — | |
| SCHEMBL11827149 | 0.72 | — | — | |
| Propene SCHEMBL28161947 | 0.71 | BRD4 (0.43) | BRD4BRD2CHRM2CHRM5CHRM1 | |
| SCHEMBL1435579 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6806334-B2 | PHARMACEUTICAL TABLET EXHIBITING RAPID DISSOLUTION AND DISINTEGRATION; MOISTURE RESISTANCE | ISP INVESTMENTS INC. | 2004-10-19 | — | — | US | claimed |
| US-20040054066-A1 | Proliferous copolymer of vinyl pyrrolidone and vinyl acetate | ISP INVESTMENTS INC. | 2004-03-18 | — | — | US | claimed |
| US-6620900-B2 | Excipient tablet with slow dissolution and disintegration | ISP INVESTMENTS INC. | 2003-09-16 | — | — | US | claimed |
| WO-2003066691-A1 | PROLIFEROUS COPOLYMER OF VINYL PYRROLIDONE AND VINYL ACETATE | ISP INVESTMENTS INC. (US) | 2003-08-14 | — | — | WO | claimed |
| US-20030153705-A1 | PROLIFEROUS COPOLYMER OF VINYL PYRROLIDONE AND VINYL ACETATE | ISP INVESTMENTS INC. | 2003-08-14 | — | — | US | claimed |
| EP-3377549-B1 | PROLIFEROUS POLYMERS COMPRISING LACTAMIC MOIETIES | ISP INVESTMENTS LLC (US) | 2024-09-04 | — | — | EP | disclosed |
| CN-115354038-A | Carbonic anhydrase immobilization method based on visible light induced graft polymerization | 陕西科技大学 | 2022-11-18 | — | — | CN | disclosed |
| CN-113120880-A | Preparation method of polymer carbon dots, polymer carbon dot film, preparation method and application | TCL集团股份有限公司 | 2021-07-16 | — | — | CN | disclosed |
| US-10844154-B2 | Proliferous copolymers comprising lactamic moieties | ISP INVESTMENTS LLC (US) | 2020-11-24 | — | — | US | disclosed |
| US-20180340034-A1 | PROLIFEROUS COPOLYMERS COMPRISING LACTAMIC MOIETIES | ISP INVESTMENTS LLC (US) | 2018-11-29 | — | — | US | disclosed |
| EP-3377549-A1 | PROLIFEROUS POLYMERS COMPRISING LACTAMIC MOIETIES | ISP Investments LLC (US) | 2018-09-26 | — | — | EP | disclosed |
| CN-102858845-A | Hydrogel precursor formulation and production process thereof | QGEL SA | 2013-01-02 | — | — | CN | disclosed |
| US-6806334-B2 | PHARMACEUTICAL TABLET EXHIBITING RAPID DISSOLUTION AND DISINTEGRATION; MOISTURE RESISTANCE | ISP INVESTMENTS INC. | 2004-10-19 | — | — | US | disclosed |
| US-20040054066-A1 | Proliferous copolymer of vinyl pyrrolidone and vinyl acetate | ISP INVESTMENTS INC. | 2004-03-18 | — | — | US | disclosed |
| US-6620900-B2 | Excipient tablet with slow dissolution and disintegration | ISP INVESTMENTS INC. | 2003-09-16 | — | — | US | disclosed |
| WO-2003066691-A1 | PROLIFEROUS COPOLYMER OF VINYL PYRROLIDONE AND VINYL ACETATE | ISP INVESTMENTS INC. (US) | 2003-08-14 | — | — | WO | disclosed |
| US-20030153705-A1 | PROLIFEROUS COPOLYMER OF VINYL PYRROLIDONE AND VINYL ACETATE | ISP INVESTMENTS INC. | 2003-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10844154-B2 | Proliferous copolymers comprising lactamic moieties | PCNA, MKI67, CCNA1 | BRD4 1116/4885BRD2 1918/4885CHRM2 4856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.